Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044.

Article  PubMed  PubMed Central  Google Scholar 

Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O et al. 2022 update on prostate Cancer epidemiology and risk Factors-A systematic review. Eur Urol. 2023.

Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS et al. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proceedings of the National Academy of Sciences. 1994;91(25):11874-8.

Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, et al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers. 2004;19(4):257–61.

Article  CAS  PubMed  Google Scholar 

Zhao X, Zhou Z, Chen Y, Chen W, Ma H, Pu J. Role of antibodies to human papillomavirus 16 in prostate cancer: a seroscreening by peptide microarray. Tumour Biol. 2017;39(6):1010428317698371.

Article  PubMed  Google Scholar 

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.

Article  CAS  PubMed  Google Scholar 

de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.

Article  PubMed  PubMed Central  Google Scholar 

Karolinska Institutet. International Human Papillomavirus (HPV) Reference Center 2023 [updated 13-09-2023. https://www.hpvcenter.se/human_reference_clones/

The International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 90 Human Papillomaviruses2007.

Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical Cancer: Epidemiology, Screening, and vaccination-review of current perspectives. J Oncol. 2019;2019:3257939.

Article  PubMed  PubMed Central  Google Scholar 

Naghashfar Z, DiPaolo JA, Woodworth CD, Passaniti A. Immortalization of human adult prostatic adenocarcinoma cells by human papilloma virus HPV16 and – 18 DNA. Cancer Lett. 1996;100(1–2):47–54.

Article  CAS  PubMed  Google Scholar 

Choo CK, Ling MT, Chan KW, Tsao SW, Zheng Z, Zhang D, et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate. 1999;40(3):150–8.

Article  CAS  PubMed  Google Scholar 

Weijerman PC, König JJ, Wong ST, Niesters HG, Peehl DM. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res. 1994;54(21):5579–83.

CAS  PubMed  Google Scholar 

Lawson JS, Glenn WK. Evidence for a causal role by human papillomaviruses in prostate cancer – a systematic review. Infect Agents Cancer. 2020;15(1).

Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate. 2013;73(3):236–41.

Article  CAS  PubMed  Google Scholar 

Chen ACH, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D, et al. Human papillomavirus in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Patients. Pathol Oncol Res. 2011;17(3):613–7.

Article  CAS  PubMed  Google Scholar 

Dillner J, Knekt P, Boman J, Lehtinen M, Af Geijersstam V, Sapp M, et al. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer. 1998;75(4):564–7.

Article  CAS  PubMed  Google Scholar 

Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, et al. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a nordic nested case-control study. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2952–5.

Article  CAS  PubMed  Google Scholar 

Sutcliffe S, Giovannucci E, Gaydos CA, Viscidi RP, Jenkins FJ, Zenilman JM, et al. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2007;16(8):1573–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sutcliffe S, Viscidi RP, Till C, Goodman PJ, Hoque AM, Hsing AW, et al. Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2010;19(2):614–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V, et al. HPV persistence and its oncogenic role in prostate tumors. J Med Virol. 2012;84(10):1636–45.

Article  CAS  PubMed  Google Scholar 

Hisada M, Rabkin CS, Strickler HD, Wright WE, Christianson RE, van den Berg BJ. Human papillomavirus antibody and risk of prostate cancer. JAMA. 2000;283(3):340–1.

Article  CAS  PubMed  Google Scholar 

Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM, et al. Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer. 2000;82(3):718–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12(8):763–8.

PubMed  Google Scholar 

Adami HO, Kuper H, Andersson SO, Bergström R, Dillner J. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2003;12(9):872–5.

PubMed  Google Scholar 

Sitas F, Urban M, Stein L, Beral V, Ruff P, Hale M, et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agents Cancer. 2007;2(1):6.

Article  Google Scholar 

Huang W-Y, Hayes R, Pfeiffer R, Viscidi RP, Lee FK, Wang YF, et al. Sexually transmissible infections and prostate Cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2374–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dennis LK, Coughlin JA, McKinnon BC, Wells TS, Gaydos CA, Hamsikova E, et al. Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2665–71.

Article  PubMed  Google Scholar 

Hrbacek J, Urban M, Hamsikova E, Tachezy R, Eis V, Brabec M, et al. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer. 2011;11(1):53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glenn WK, Ngan CC, Amos TG, Edwards RJ, Swift J, Lutze-Mann L et al. High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer. Infect Agents Cancer. 2017;12(1).

Chen Y, Wei J. Identification of Pathogen signatures in prostate Cancer using RNA-seq. PLoS ONE. 2015;10(6):e0128955.

Article  PubMed  PubMed Central  Google Scholar 

Tang K-W, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun. 2013;4(1).

Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, et al. Landscape of DNA Virus associations across Human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013;87(16):8916–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersen K, Holm K, Tranberg M, Pedersen CL, Bønløkke S, Steiniche T et al. Targeted next generation sequencing for human papillomavirus genotyping in cervical liquid-based cytology samples. Cancers (Basel). 2022;14(3).

Salachan PV, Rasmussen M, Fredsøe J, Ulhøi B, Borre M, Sørensen KD. Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling. Genome Med. 2022;14(1).

Pinskaya M, Saci Z, Gallopin M, Gabriel M, Nguyen HT, Firlej V et al. Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis. Life Sci Alliance. 2019;2(6).

Strand SH, Switnicki M, Moller M, Haldrup C, Storebjerg TM, Hedegaard J, et al. RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Oncotarget. 2017;8(4):5774–8.

Article  PubMed  Google Scholar 

Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985;314(6006):111–4.

Article  CAS  PubMed